Too few eat enough fruits/vegetables. #diet @CDCgov https://t.co/g33gBgzG37
Month: November 2017
Tweet The rebirth of cyclosporine? ( or …
The rebirth of cyclosporine? ( or do you spell it without an e at the end) #amjgastro @AmCollegeGastro https://t.co/rOrJBxvJdv
Tweet Interesting to see coffee on list …
Interesting to see coffee on list of #NASH interventions @NEJM I must admit that not 100% sold on #Coffee & think… https://t.co/L5EFIiG7AG
Tweet Some good news for #IBD patients. …
Some good news for #IBD patients. No impact on paternity rates in men with #ulcerativecolitis. @AmCollegeGastro… https://t.co/8BvVX1hOl8
GI Pearls – October 16 – November 10 2017 – Episode 12
Podcast: Play in new window | Download
Subscribe: Apple Podcasts | RSS
Show Notes for October 16- November 10 – Episode 12
- A comparison of the resection rate for cold and hot snare polypectomy for 4–9 mm colorectal polyps: a multicentre randomised controlled trial – GUT.
- Impact of preprocedure simethicone on adenoma detection rate during colonoscopy – Endoscopy
- Laparoscopic ileocaecal resection versus infliximab for terminal ileitis in Crohn’s disease: a randomised controlled, open-label, multicentre trial – The Lancet – Gastro
- Modifiable factors associated with patient-reported pain during and after screening colonoscopy – Gut
- Accuracy and Safety of the Cytosponge for Asessment of Histologic Activity in EOE: Two center study – Am J Gastro
- Air Insufflation May Still be Ideal For Adenoma Detection – Am J Gastro
- Patients with Crohn’s Disease with High Body Mass Index Present More Frequent and Rapid Loss of Response to Infliximab – IBD journal
- Anesthesia Assistance in outpatient colonoscopy and risk of aspiration pneumonia, bowel perforation, and splenic injury. – Gastro
- Increased Risk for Mother-to-Infant Transmission of HCV Among Medicaid Recipience – Wisconsin – MMWR
- Upper gastrointestinal complications following ablation therapy for atrial fibrillation – NeuroGastro&Motility
- Hemorrhagic angiodysplasia of the digestive tract – GIE
- Colorectal cancer screening with the fecal immunochemical test in persons aged 30 to 49 years: focusing on the age for commencing screening – GIE